The first step has been taken towards developing a nanorobot that – in the long run – will enable the targeted transport of medications in the body.
A nanorobot is a popular term for molecules with a unique property that enables them to be programmed to carry out a specific task. In collaboration with colleagues in Italy and the USA, researchers at Aarhus University have now taken a major step towards building the first nanorobot of DNA molecules that can encapsulate and release active biomolecules.
In time, the nanorobot (also called a DNA nanocage) will no doubt be used to transport medications around in the body and thereby have a targeted effect on diseased cells.
Design using the body’s natural molecules
Using DNA self-assembly, the researchers designed eight unique DNA molecules from the body’s own natural molecules. When these molecules are mixed together, they spontaneously aggregate in a usable form – the nanocage (see figure).
The nanocage has four functional elements that transform themselves in response to changes in the surrounding temperature. These transformations either close (figure 1A) or open (figure 1B) the nanocage. By exploiting the temperature changes in the surroundings, the researchers trapped an active enzyme called horseradish peroxidase (HRP) in the nanocage (figure 1C). They used HRP as a model because its activity is easy to trace.
This is possible because the nanocage’s outer lattice has apertures with a smaller diameter than the central spherical cavity. This structure makes it possible to encapsulate enzymes or other molecules that are larger than the apertures in the lattice, but smaller than the central cavity.
The researchers have just published these results in the renowned journal ACS Nano. Here the researchers show how they can utilise temperature changes to open the nanocage and allow HRP to be encapsulated before it closes again.
They also show that HRP retains its enzyme activity inside the nanocage and converts substrate molecules that are small enough to penetrate the nanocage to products inside.
The encapsulation of HRP in the nanocage is reversible, in such a way that the nanocage is capable of releasing the HRP once more in reaction to temperature changes. The researchers also show that the DNA nanocage – with its enzyme load – can be taken up by cells in culture.
Looking towards the future, the concept behind this nanocage is expected to be used for drug delivery, i.e. as a means of transport for medicine that can target diseased cells in the body in order to achieve a more rapid and more beneficial effect.
The Latest on: Drug delivery
via Google News
The Latest on: Drug delivery
- Novel Drug Delivery Systems in Cancer Therapy Market Statistics and Research Analysis Released in Latest Reporton January 10, 2020 at 3:43 am
The “Novel Drug Delivery Systems in Cancer Therapy Market Analysis to 2030” is a specialized and in-depth study of the Novel Drug Delivery Systems in Cancer Therapy industry with a focus on the Novel ...
- Connected Drug Delivery Devices Market is Anticipated to Expand at a Healthy CAGR of 25.6% During the Forecast Period 2015 - 2027on January 10, 2020 at 3:33 am
VALLEY COTTAGE, N.Y. - The market for connected drug delivery devices is foreseen to witness a stellar growth rate of 25.6% from 2015 to 2027 rising to a valuation of US$ 1,304.7 Mn from US$ 132.2 Mn ...
- Injectable Drug Delivery Market 2020: Size, Share, Growth, Trends and Regional Forecast | Fortune Business Insights™on January 9, 2020 at 2:55 am
The rising prevalence of chronic diseases such as diabetes, cancer, and others is boosting the global injectable drug delivery market. Fortune Business Insights in a report, titled “INJECTABLE DRUG ...
- Global Needle-Free Drug Delivery Devices Market 2020-2024 | Evolving Opportunities with 3M Co. and Antares Pharma Inc. | Technavioon January 8, 2020 at 4:09 pm
The global needle-free drug delivery devices market is poised to grow by USD 10.23 billion during 2020-2024, according to Technavio.
- Phillips-Medisize Expands Clinical Manufacturing Capabilities to Serve Growing Drug Delivery Device Marketon January 8, 2020 at 8:20 am
As a recognized global leader, Phillips-Medisize provides a wide range of custom drug delivery devices, connected health solutions and end-to-end manufacturing services worldwide. The ...
- Drug Delivery: Global Injection Devices Market...on January 6, 2020 at 11:39 pm
Dublin, Jan. 07, 2020 (GLOBE NEWSWIRE) -- The "Drug Delivery: Injection Devices" report has been added to ResearchAndMarkets.com's offering. Despite its relative invasiveness and technological ...
- Pulmatrix teams up with Nocion Therapeutics in inhaled drug deliveryon January 6, 2020 at 2:02 pm
Pulmatrix (PULM +8.6%) will collaborate with Nocion Therapeutics on research aimed at exploring new technologies to enable and improve inhaled drug delivery, specifically leveraging the former's ...
- Lancaster fentanyl dealer gets max sentence for 2017 drug delivery resulting in deathon January 6, 2020 at 7:39 am
LANCASTER COUNTY, Pa.– A Lancaster man will serve at least 23½ years in prison for selling fentanyl, including a drug delivery resulting in death in 2017. Kim Burgess, 39, was sentenced to serve up to ...
- Pulmatrix Announces Research Collaboration with Nocion Therapeutics to Explore Inhaled Drug Delivery Technologieson January 6, 2020 at 4:58 am
/PRNewswire/ -- Pulmatrix, Inc. (NASDAQ: PULM), a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious ...
- Drug Delivery Market is boosted by Increasing Demand for High-quality Meat to Encourage Growth - 2025on January 3, 2020 at 10:56 pm
This intelligence report provides a comprehensive analysis of the "Global Drug Delivery Market. This includes Investigation of past progress, ongoing market scenarios, and future prospects. Data True ...
via Bing News